Ikuya Miki

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 232 citations

Medicine, Oncology, Surgery +11

Primary Levofloxacin Resistance and <i>gyrA/B</i> Mutations Among <i>Helicobacter pylori</i> in Japan

Hideyuki Miyachi, Ikuya Miki, Nobuo Aoyama et al. · Helicobacter · 2006 · 141 citations

Life Sciences, Infectious Diseases, Microbiology +17

Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis

Shigeto Mizuno, Ikuya Miki, Tsukasa Ishida et al. · Digestive Diseases and Sciences · 2010 · 105 citations

Medicine, Microbiology, Oncology +17

MDR1 Haplotype Frequencies in Japanese and Caucasian, and in Japanese Patients with Colorectal Cancer and Esophageal Cancer

Chiho Komoto, Tsutomu Nakamura, Toshiyuki Sakaeda et al. · Drug Metabolism and Pharmacokinetics · 2006 · 94 citations

Medicine, Genetics, Oncology +6

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

Ikuya Miki, Nobuo Aoyama, Toshiyuki Sakai et al. · European Journal of Gastroenterology & Hepatology · 2003 · 72 citations

Medicine, Pharmacology, Pharmacotherapy +15